Skip to content

Exocure™ innovative patents and exosome-delivery technology will ensure successful outcomes for patients and clinicians to develop advanced medicines to achieve progress in otherwise incurable diseases. We thank you for your interest in this innovative biotechnology opportunity.

For further inquiries, please contact:

Exocure
[email protected]

Søren Melsing, CEO
[email protected]

Jan Lötvall, MD PhD, Professor and Founder
[email protected]

Mats Persson, Chairman of the Board, Co-Founder
[email protected]